FDA Issues Important Guidance Documents On Drug Risk Management Plans And Out-of-Specification Test Results - Healthcare
In May 2022, the US Food and Drug Administration (FDA), released two important guidance documents: Risk Management Plans to Mitigate the Potential for Drug Shortages Guidance for Industry...
Public Health Service Development Strategy Drug Administration Risk Management Plans Drug Shortages Guidance Investigating Out Of Specification
Source: mondaq.com